Sanofi ADR (SNY) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Sanofi ADR

NASDAQ | SNY

52.22

USD

-2.4 (-4.39%)

AT CLOSE (AS OF Apr 4, 2025)

$134B

MARKET CAP

23.05

P/E Ratio

2.37

EPS

$60

52 Week High

$45

52 Week Low

LIFE SCIENCES

Sector

SNY Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

SNY Technicals

Tags:

SNY Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field	Value (EUR)
Gross Profit	$31B
Total Revenue	$44B
Cost Of Revenue	$13B
Costof Goods And Services Sold	$13B
Operating Income	$7.3B
Selling General And Administrative	$9.2B
Research And Development	$7.4B
Operating Expenses	$24B
Investment Income Net	-
Net Interest Income	-$560M
Interest Income	$413M
Interest Expense	$749M
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$3.6B
Income Before Tax	$6.7B
Income Tax Expense	$1.2B
Interest And Debt Expense	-
Net Income From Continuing Operations	$5.6B
Comprehensive Income Net Of Tax	-
Ebit	$7.4B
Ebitda	$11B
Net Income	$5.6B

Revenue & Profitability

Earnings Performance

SNY Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2024)

Field	Value (EUR)
Total Assets	$133B
Total Current Assets	$43B
Cash And Cash Equivalents At Carrying Value	$7.4B
Cash And Short Term Investments	$7.4B
Inventory	$9.4B
Current Net Receivables	-
Total Non Current Assets	$90B
Property Plant Equipment	-
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	$23B
Intangible Assets Excluding Goodwill	$23B
Goodwill	$43B
Investments	-
Long Term Investments	$3.3B
Short Term Investments	$486M
Other Current Assets	$15B
Other Non Current Assets	-
Total Liabilities	$55B
Total Current Liabilities	$29B
Current Accounts Payable	-
Deferred Revenue	-
Current Debt	-
Short Term Debt	$4.5B
Total Non Current Liabilities	$26B
Capital Lease Obligations	$1.9B
Long Term Debt	$12B
Current Long Term Debt	$4.2B
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$18B
Other Current Liabilities	$16B
Other Non Current Liabilities	$2.9B
Total Shareholder Equity	$78B
Treasury Stock	-
Retained Earnings	-
Common Stock	$2.5B
Common Stock Shares Outstanding	$1.3B

yearly Cash Flow (As of Dec 31, 2024)

Field	Value (EUR)
Operating Cashflow	$9.1B
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-
Change In Operating Assets	-
Depreciation Depletion And Amortization	$3.6B
Capital Expenditures	$3.2B
Change In Receivables	-
Change In Inventory	-$477M
Profit Loss	-
Cashflow From Investment	-
Cashflow From Financing	-$5.8B
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	$4.7B
Dividend Payout Common Stock	$4.7B
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-$302M
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	$5.5B

yearly Income Statement (As of Dec 31, 2024)

Field	Value (EUR)
Gross Profit	$31B
Total Revenue	$44B
Cost Of Revenue	$13B
Costof Goods And Services Sold	$13B
Operating Income	$7.3B
Selling General And Administrative	$9.2B
Research And Development	$7.4B
Operating Expenses	$24B
Investment Income Net	-
Net Interest Income	-$560M
Interest Income	$413M
Interest Expense	$749M
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$3.6B
Income Before Tax	$6.7B
Income Tax Expense	$1.2B
Interest And Debt Expense	-
Net Income From Continuing Operations	$5.6B
Comprehensive Income Net Of Tax	-
Ebit	$7.4B
Ebitda	$11B
Net Income	$5.6B

Dividends

Field	Value
Ex Dividend Date	2024-05-09
Declaration Date	2024-03-26
Record Date	2024-05-10
Payment Date	2024-06-06
Amount	2.037356

SNY Profile

Sanofi ADR Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company is headquartered in Paris, France.

Symbol	Price	Change %	Market Cap	Volume
NVDA	$94.14	-7.53%	$2.68T	411,170,358
MULN	$0.08	1.38%	$422.46K	345,269,025
DMN	$0.01	-11.26%	-	268,027,311
WCT	$0.28	44.82%	$100.86M	194,859,194
TSLA	$243.94	-8.73%	$909.50B	158,373,844

Symbol	Price	Change %	Market Cap	Volume
JNJ	$154.10	-3.58%	$399.65B	8,937,614
PG	$164.82	-4.39%	$399.61B	8,625,731
ABBV	$188.93	-6.31%	$364.89B	7,519,295
NVO	$62.96	-6.18%	$308.32B	8,844,093
ABT	$125.07	-4.98%	$228.39B	6,931,084

Symbol	Price	Change %	Market Cap	Volume
AEHL	$4.37	8,224.00%	$3.18M	9,081,262
SOBR	$4.80	1,282.89%	$396.44K	1,198,915
FTFT	$1.30	909.55%	$3.27M	191,485
CISS	$3.90	575.32%	$2.68M	453,876
AREB	$15.68	295.96%	$3.77M	80,381,536

Symbol	Price	Change %	Market Cap	Volume
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
MMV	$0.48	-51.02%	$11.90M	1,568,644
KRBP	$0.16	-48.72%	$424.82K	107,749

Quick Links

SNY $52.22 (-4.39%) Quote details